Keywords: XTL Biopharmaceuticals, Kitov Pharmaceuticals, M&A, Israel

XTL Biopharma to acquire Kitov Pharmaceuticals

Article | 21 June 2012

Print This

Israeli biopharma firm XTL Biopharmaceuticals (TASE:XTL) says it will acquire fellow Israel-based Kitov Pharmaceuticals in a share and cash ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in